Skip to main content

Table 1 Spontaneous models of Sjögren's syndrome

From: Sjögren's syndrome: studying the disease in mice

Strain/modificationa

SS-like disease manifestationsb

Remarksb

Reference

(NZB/NZW)F1

SG and LG infl.

SLE-like disease

[19]

MRL

SG and LG infl.

SLE-like disease

[29]

    lpr

   ↑ SG and LG infl.

   lpr exacerbates the MRL disease phenotype

[30]

NFS/sld

None

Aberrant proteolysis of α-fodrin

[33]

   3d-Tx

   SG and LG infl.

   Inflammatory lesions in multiple organs

[34]

IQI/Jic

   SG and LG infl.

Inflammatory lesions in multiple organs

[37]

NOD

SG and LG infl., ↓ SG and LG function

T1D, multiple immune system-related alterations

[12]

    H2b

   Similar to original NOD strain

No T1D

[42]

C57BL/6

May develop SG infl. at an old age

   Widely used recipient strain

 

   NOD-Aec1Aec2

   SG and LG infl., ↓ SG and LG function

   Increased applicability compared with NOD mice

[41]

    Il2-/-

   SG and LG infl., ↓ SG function

   Generalized lymphoproliferative disease

[91]

    Il2Rα-/-

   SG and LG infl., ↓ SG function

   Generalized lymphoproliferative disease

[91]

    Foxp3-/-

   None

   More susceptible to SS-like disease

[94]

   Il10 Tg

   SG and LG infl., ↓ SG and LG function

   ↑ apoptosis in the SG

[95]

   Il14α Tg

   SG infl., ↓ SG function

   High incidence of CD5+ lymphoma, nephritis

[101]

   Baff Tg

   SG and LG infl., ↓ SG function

   MZ B-cell dominated infl., SLE-like disease

[106]

    Tgfβ1-/-

   SG and LG infl., ↓ SG function

   Poor viability, mixed inflammatory cell response

[112]

   Tgfβ1 Tg

   ↓ SG function

   Impaired SG architecture, SG tissue fibrosis

[113]

    Thbs1-/-

   LG infl., anti-Ro and anti-La

   Detailed assessment of the eye component

[116]

    Ar -/-

   SG infl.

   Estrogen-dependent disease

[119]

   RbAp48 Tg

   SG and LG infl., ↓ SG function, anti-Ro and anti-La

   Assessment of the inflammatory milieu in the SG

[122]

    Id3-/-

   SG and LG infl., ↓ SG function, anti-Ro and anti-La

   Exocrine gland dysfunction precedes SG and LG infl.

[125]

    Id3-/-;LckCre

   SG and LG infl., ↓ SG function, anti-Ro and anti-La

   T-cell lineage specific deletion of Id3

[126]

   r1ΔT/r2n

   SG and LG infl., anti-Ro

   ↓ Tregs, inflammatory lesions in multiple organs

[130]

    IκBαM/M

   SG and LG infl., anti-Ro and anti-La

   Defective feedback regulation of NF-κB

[133]

C57BL/10

May develop SG infl. at an old age

C57BL/6 and C57BL/10 diverged prior to 1937

 

   NOD-Nss1/Idd5

   SG infl.

   SG function has not been assessed

[82]

SJL

SG and LG infl., anti-Ro and anti-La

Susceptible to multiple autoimmune diseases

[98]

   Il12 Tg

   ↑ SG and LG infl., ↓ SG function, ↑ anti-Ro and anti-La

   IL-12 exacerbates the SJL disease phenotype

[98]

BALB/c

None

Often used as control strain

 

    Act1-/-

   SG and LG infl., anti-Ro and anti-La

   MZ B-cell dominated infl., SLE-like disease

[115]

  1. Selection of murine strains in which Sjögren's syndrome (SS)-like disease manifestations develop spontaneously. ↑, increased; ↓, decreased; Ar, aromatase; 3d-Tz, 3 days after birth thymectomy; infl., inflammation; LG, lacrimal gland; MZ, marginal zone; NOD, nonobese diabetic mice; SG, salivary gland; SLE, systemic lupus erythematosus; T1D, type 1 diabetes; Tg, transgenic; Treg, regulatory T cell. aSpecific modification of the original strain. bFor modified strains, listings refer to relative changes compared with the original, not indented, strain listed above.